Hemin-Induced Mast Cell-Extracellular Traps Impart Resistance to Therapy in a Sickle Microenvironment
Mast cell activation in the skin contributes to inflammation, neurogenic inflammation and hyperalgesia in sickle mice (Vincent et al., Blood 2013). However, the underlying cause of mast cell activation and challenges in inhibiting mast cell activation remain unclear. Hemolysis in sickle cell disease...
Saved in:
Published in | Blood Vol. 126; no. 23; p. 3385 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
03.12.2015
|
Online Access | Get full text |
Cover
Loading…
Abstract | Mast cell activation in the skin contributes to inflammation, neurogenic inflammation and hyperalgesia in sickle mice (Vincent et al., Blood 2013). However, the underlying cause of mast cell activation and challenges in inhibiting mast cell activation remain unclear. Hemolysis in sickle cell disease leads to excess free heme, which contributes to endothelial activation and neutrophil extracellular trap (NET) formation. We therefore hypothesized that free heme activates mast cells and extracellular trap formation in a sickle microenvironment. We examined hemin-induced activation in mast cells from the skin of HbAA-BERK control and HbSS-BERK sickle mice. Mast cells in culture were incubated with vehicle, or I ng/ml TNF-α for 4 hours, or 40 μM hemin for 2 hours, or with hemin for 2 hours after 2 hours of priming with TNF-α to create an inflammatory sickle microenvironment. Cells were stained with cell impermeable DNA dye SYTOX orange and cell permeable dye SYTO13 to visualize the extracellular DNA fibers. Incubation with TNF-α or hemin did not show significant eruption of DNA from the cell body. However, sickle mast cells incubated with both TNF-α and hemin showed distinct DNA containing fibers exploding from the cell body with the appearance of spider web like formation similar to NETs. The length of majority of individual fibers was more than 50 μm stretching to more than 500 μM, indicative of TRAP formation. This response was blunted in mast cells from control mice. Thus, mast cells in a sickle microenvironment are primed and activated, and further priming with cytokines such as TNF-α leads to hemin-induced mast cell extracellular trap (MET) formation. Sickle mast cells express significantly higher TLR4 and FcεRI as compared to control mice (Vincent et al., Blood 2013). Therefore, we examined if silencing of FcεRI and/or inhibition of TLR4 attenuated TNF-α primed/hemin-induced MET formation. TAK242 at a dose of 1 μM but not at 0.5 μM inhibited TNF-α primed/hemin-induced MET formation, but silencing of FcεRI had no effect. Since cannabinoids, imatinib, palmitoylethanolamide (PEA) and cromolyn are known mast cell inhibitors, we examined their effect on TNF-α/hemin-induced METs. Imatinib (30 - 100 μM), a known mast cell inhibitor, showed no significant effect, while cromolyn (100 μM) led to a modest decrease in MET formation. Cannabinoid CP 55,940 and PEA at a relatively low dose of 30 μM completely blocked MET formation. Functionally, imatinib, PEA and CP 55,940 reduced the release of cytokines TNF-α and RANTES from mast cells incubated with TNF-α/hemin for 24 hours. Hemin in the presence of TNF-α stimulated sustained activation of NLRP3 inflammasome signaling. Thus, mast cells in a sickle microenvironment are activated due to a rich inflammatory cytokine milieu, via activation of the inflammasome signaling upon stimulation with hemin. The unique phenomenon of MET formation is orchestrated by a combined action of inflammatory milieu and hemin, imparting resistance to common mast cell inhibitors such as cromolyn and imatinib. This new phenomenon of MET formation identified by us may in part contribute to challenges of treating sickle cell disease and other mast cell associated pathological conditions.
No relevant conflicts of interest to declare. |
---|---|
AbstractList | Mast cell activation in the skin contributes to inflammation, neurogenic inflammation and hyperalgesia in sickle mice (Vincent et al., Blood 2013). However, the underlying cause of mast cell activation and challenges in inhibiting mast cell activation remain unclear. Hemolysis in sickle cell disease leads to excess free heme, which contributes to endothelial activation and neutrophil extracellular trap (NET) formation. We therefore hypothesized that free heme activates mast cells and extracellular trap formation in a sickle microenvironment. We examined hemin-induced activation in mast cells from the skin of HbAA-BERK control and HbSS-BERK sickle mice. Mast cells in culture were incubated with vehicle, or I ng/ml TNF-α for 4 hours, or 40 μM hemin for 2 hours, or with hemin for 2 hours after 2 hours of priming with TNF-α to create an inflammatory sickle microenvironment. Cells were stained with cell impermeable DNA dye SYTOX orange and cell permeable dye SYTO13 to visualize the extracellular DNA fibers. Incubation with TNF-α or hemin did not show significant eruption of DNA from the cell body. However, sickle mast cells incubated with both TNF-α and hemin showed distinct DNA containing fibers exploding from the cell body with the appearance of spider web like formation similar to NETs. The length of majority of individual fibers was more than 50 μm stretching to more than 500 μM, indicative of TRAP formation. This response was blunted in mast cells from control mice. Thus, mast cells in a sickle microenvironment are primed and activated, and further priming with cytokines such as TNF-α leads to hemin-induced mast cell extracellular trap (MET) formation. Sickle mast cells express significantly higher TLR4 and FcεRI as compared to control mice (Vincent et al., Blood 2013). Therefore, we examined if silencing of FcεRI and/or inhibition of TLR4 attenuated TNF-α primed/hemin-induced MET formation. TAK242 at a dose of 1 μM but not at 0.5 μM inhibited TNF-α primed/hemin-induced MET formation, but silencing of FcεRI had no effect. Since cannabinoids, imatinib, palmitoylethanolamide (PEA) and cromolyn are known mast cell inhibitors, we examined their effect on TNF-α/hemin-induced METs. Imatinib (30 - 100 μM), a known mast cell inhibitor, showed no significant effect, while cromolyn (100 μM) led to a modest decrease in MET formation. Cannabinoid CP 55,940 and PEA at a relatively low dose of 30 μM completely blocked MET formation. Functionally, imatinib, PEA and CP 55,940 reduced the release of cytokines TNF-α and RANTES from mast cells incubated with TNF-α/hemin for 24 hours. Hemin in the presence of TNF-α stimulated sustained activation of NLRP3 inflammasome signaling. Thus, mast cells in a sickle microenvironment are activated due to a rich inflammatory cytokine milieu, via activation of the inflammasome signaling upon stimulation with hemin. The unique phenomenon of MET formation is orchestrated by a combined action of inflammatory milieu and hemin, imparting resistance to common mast cell inhibitors such as cromolyn and imatinib. This new phenomenon of MET formation identified by us may in part contribute to challenges of treating sickle cell disease and other mast cell associated pathological conditions.
No relevant conflicts of interest to declare. Abstract Mast cell activation in the skin contributes to inflammation, neurogenic inflammation and hyperalgesia in sickle mice (Vincent et al., Blood 2013). However, the underlying cause of mast cell activation and challenges in inhibiting mast cell activation remain unclear. Hemolysis in sickle cell disease leads to excess free heme, which contributes to endothelial activation and neutrophil extracellular trap (NET) formation. We therefore hypothesized that free heme activates mast cells and extracellular trap formation in a sickle microenvironment. We examined hemin-induced activation in mast cells from the skin of HbAA-BERK control and HbSS-BERK sickle mice. Mast cells in culture were incubated with vehicle, or I ng/ml TNF-α for 4 hours, or 40 μM hemin for 2 hours, or with hemin for 2 hours after 2 hours of priming with TNF-α to create an inflammatory sickle microenvironment. Cells were stained with cell impermeable DNA dye SYTOX orange and cell permeable dye SYTO13 to visualize the extracellular DNA fibers. Incubation with TNF-α or hemin did not show significant eruption of DNA from the cell body. However, sickle mast cells incubated with both TNF-α and hemin showed distinct DNA containing fibers exploding from the cell body with the appearance of spider web like formation similar to NETs. The length of majority of individual fibers was more than 50 μm stretching to more than 500 μM, indicative of TRAP formation. This response was blunted in mast cells from control mice. Thus, mast cells in a sickle microenvironment are primed and activated, and further priming with cytokines such as TNF-α leads to hemin-induced mast cell extracellular trap (MET) formation. Sickle mast cells express significantly higher TLR4 and FcεRI as compared to control mice (Vincent et al., Blood 2013). Therefore, we examined if silencing of FcεRI and/or inhibition of TLR4 attenuated TNF-α primed/hemin-induced MET formation. TAK242 at a dose of 1 μM but not at 0.5 μM inhibited TNF-α primed/hemin-induced MET formation, but silencing of FcεRI had no effect. Since cannabinoids, imatinib, palmitoylethanolamide (PEA) and cromolyn are known mast cell inhibitors, we examined their effect on TNF-α/hemin-induced METs. Imatinib (30 - 100 μM), a known mast cell inhibitor, showed no significant effect, while cromolyn (100 μM) led to a modest decrease in MET formation. Cannabinoid CP 55,940 and PEA at a relatively low dose of 30 μM completely blocked MET formation. Functionally, imatinib, PEA and CP 55,940 reduced the release of cytokines TNF-α and RANTES from mast cells incubated with TNF-α/hemin for 24 hours. Hemin in the presence of TNF-α stimulated sustained activation of NLRP3 inflammasome signaling. Thus, mast cells in a sickle microenvironment are activated due to a rich inflammatory cytokine milieu, via activation of the inflammasome signaling upon stimulation with hemin. The unique phenomenon of MET formation is orchestrated by a combined action of inflammatory milieu and hemin, imparting resistance to common mast cell inhibitors such as cromolyn and imatinib. This new phenomenon of MET formation identified by us may in part contribute to challenges of treating sickle cell disease and other mast cell associated pathological conditions. Disclosures No relevant conflicts of interest to declare. |
Author | Rodriguez, Jonathan Jha, Ritu Lei, Jianxun Nguyen, Julia Tran, Huy Gupta, Kalpna Jarrett, Sarita Mittal, Aditya |
Author_xml | – sequence: 1 givenname: Huy surname: Tran fullname: Tran, Huy organization: Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN – sequence: 2 givenname: Ritu surname: Jha fullname: Jha, Ritu organization: Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN – sequence: 3 givenname: Julia surname: Nguyen fullname: Nguyen, Julia organization: Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN – sequence: 4 givenname: Sarita surname: Jarrett fullname: Jarrett, Sarita organization: Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN – sequence: 5 givenname: Jonathan surname: Rodriguez fullname: Rodriguez, Jonathan organization: Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN – sequence: 6 givenname: Aditya surname: Mittal fullname: Mittal, Aditya organization: Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN – sequence: 7 givenname: Jianxun surname: Lei fullname: Lei, Jianxun organization: Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN – sequence: 8 givenname: Kalpna surname: Gupta fullname: Gupta, Kalpna organization: Vascular Biology Center, Division of Hematology, Oncology & Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN |
BookMark | eNqFkN1OAjEQhRuDiYA-g32BxWm73Z9LQlBIICaK3jbddjZWd7ukXYm8vQt4782ZSSbnzMw3ISPfeSTknsGMsYI_VE3X2dk749mMi5kQhTzLFRkzyYsEgMOIjAEgS9IyZzdkEuMnAEsFl2OCK2ydT9befhu0dKtjTxfYNMnypw_aDN13owPdBb2PdN3udejpC0YXe-0N0r6juw8chkfqPNX01ZmvBunWmdChP7jQ-RZ9f0uua91EvPurU_L2uNwtVsnm-Wm9mG8SwzKQSVnW1hioJdg6tRLTrOJMClHqXDLDsBQ85TovZQ5Gl3mWiQoyC7qWsiqqVIgpyS-5w_oYA9ZqH1yrw1ExUCda6kxLnWgpLtQJ1FkG5_zixOG8g8OgonE4vGhdQNMr27l_M34B5OR3ng |
CitedBy_id | crossref_primary_10_1097_MOH_0000000000000491 crossref_primary_10_1111_imr_12622 crossref_primary_10_1016_j_bcmd_2019_102399 crossref_primary_10_1089_ars_2023_0329 crossref_primary_10_1007_s00011_016_0955_9 |
ContentType | Journal Article |
Copyright | 2015 American Society of Hematology |
Copyright_xml | – notice: 2015 American Society of Hematology |
DBID | 6I. AAFTH AAYXX CITATION |
DOI | 10.1182/blood.V126.23.3385.3385 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Biology Anatomy & Physiology |
EISSN | 1528-0020 |
EndPage | 3385 |
ExternalDocumentID | 10_1182_blood_V126_23_3385_3385 S000649711850375X |
GroupedDBID | --- -~X .55 1CY 23N 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6I. 6J9 AAEDW AAFTH AAXUO ABOCM ABVKL ACGFO ADBBV AENEX AFOSN AHPSJ ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD EX3 F5P FDB FRP GS5 GX1 IH2 K-O KQ8 L7B LSO MJL N9A OK1 P2P R.V RHF RHI ROL SJN THE TR2 TWZ W2D W8F WH7 WOQ WOW X7M YHG YKV ZA5 0R~ 0SF AALRI AAYXX ADVLN AITUG AKRWK AMRAJ CITATION H13 |
ID | FETCH-LOGICAL-c1605-99fdcc0f50df4d5e46b215339a751c1e93242a79570ca97663b06d0af55b8b433 |
IEDL.DBID | ABVKL |
ISSN | 0006-4971 |
IngestDate | Fri Aug 23 01:46:38 EDT 2024 Fri Feb 23 02:43:40 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 23 |
Language | English |
License | This article is made available under the Elsevier license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c1605-99fdcc0f50df4d5e46b215339a751c1e93242a79570ca97663b06d0af55b8b433 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S000649711850375X |
PageCount | 1 |
ParticipantIDs | crossref_primary_10_1182_blood_V126_23_3385_3385 elsevier_sciencedirect_doi_10_1182_blood_V126_23_3385_3385 |
PublicationCentury | 2000 |
PublicationDate | 2015-12-03 |
PublicationDateYYYYMMDD | 2015-12-03 |
PublicationDate_xml | – month: 12 year: 2015 text: 2015-12-03 day: 03 |
PublicationDecade | 2010 |
PublicationTitle | Blood |
PublicationYear | 2015 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
SSID | ssj0014325 |
Score | 2.2218318 |
Snippet | Mast cell activation in the skin contributes to inflammation, neurogenic inflammation and hyperalgesia in sickle mice (Vincent et al., Blood 2013). However,... Abstract Mast cell activation in the skin contributes to inflammation, neurogenic inflammation and hyperalgesia in sickle mice (Vincent et al., Blood 2013).... |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | 3385 |
Title | Hemin-Induced Mast Cell-Extracellular Traps Impart Resistance to Therapy in a Sickle Microenvironment |
URI | https://dx.doi.org/10.1182/blood.V126.23.3385.3385 |
Volume | 126 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3faxQxEB7aK2pfil4VW7XkQXzL3W5-7ca369FyWk9Q23JvSzabhYO6PXor6H_vTHZXKhR88CWEhUB2Jsx8k_kyA_AWPWJFJXM4en_DlXclt8oKrkyt61S61MQiScvPZnGlPq70agfmw1sYolX2tr-z6dFa91-mvTSnm_Wa3viiO7UZImRNjVxXu7AnMpOIEezNTq8vPv1JJigpukYGtBtc0NO8EFlPIzt8cp0KMxFyguGajsPDTuqe4zl_Cgc9YmSzblPPYCc0YzicNRgtf__F3rHI4YyX42N4dDrMnsyHTm5jeLzsE-iHEBZUTIRTww78dbZ025bNw80NP_vZ3jm6xSdaKkMPttmyD0RPb9nXsCWQiZJh7S277MoQsHXDHPu2pswwWxKr796TuedwdX52OV_wvtMC9ynGM9zauvI-qXVS1arSQZlSEBC0LtOpT4Ml2OUyq7PEOwQwRpaJqRJXa13mpZLyBYya2ya8BJblXqARyHPprfKlsCWGcFRkzqg8JFl9BMkg2mLTFdQoYiCSiyJqoyBtFEIWpIg4HMH7QQXFX2ejQLP_r8XH_7P4FewjQNKRviJfw6i9-xHeIAhpy5P-kJ3A7sWX_Dfm29cD |
link.rule.ids | 315,786,790,27602,27957,27958,45698 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEB7SDW16Ke2mpelTh9Kbdm29bPW2WRI2zTqHdhP2JmRZhoXUWbIuJP--I9kuKRR66EUIg0CeETPfaD7NAHxCj1iFkjkUvb-iwtmSaqEZFaqWdcptqmKRpOJCLS7F17Vc78F8eAsTaJW97e9serTW_ZdpL83pdrMJb3zRneoMEbIMjVzXj2Af0YDOR7A_O746X_5OJgjOukYGYTe4oKd5IbKeRnb45CplasL4BMM1GYe_O6kHjuf0OTzrESOZdZt6AXu-GcPhrMFo-cc9-UwihzNejo_h8fEwO5gPndzG8KToE-iH4BehmAgNDTvw10lhdy2Z--trenLX3tpwix9oqQQ92HZHzgI9vSXf_C6ATJQMaW_IqitDQDYNseT7JmSGSRFYfQ-ezL2Ey9OT1XxB-04L1KUYz1Ct68q5pJZJVYtKeqFKFoCgtplMXep1gF020zJLnEUAo3iZqCqxtZRlXgrOX8GouWn8ayBZ7hgagTznTgtXMl1iCBeKzCmR-ySrjyAZRGu2XUENEwORnJmoDRO0YRg3QRFxOIIvgwrMH2fDoNn_1-I3_7P4IxwsVsXSLM8uzt_CUwRLMlJZ-DsYtbc__XsEJG35oT9wvwAt9dkH |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hemin-Induced+Mast+Cell-Extracellular+Traps+Impart+Resistance+to+Therapy+in+a+Sickle+Microenvironment&rft.jtitle=Blood&rft.au=Tran%2C+Huy&rft.au=Jha%2C+Ritu&rft.au=Nguyen%2C+Julia&rft.au=Jarrett%2C+Sarita&rft.date=2015-12-03&rft.pub=Elsevier+Inc&rft.issn=0006-4971&rft.eissn=1528-0020&rft.volume=126&rft.issue=23&rft.spage=3385&rft.epage=3385&rft_id=info:doi/10.1182%2Fblood.V126.23.3385.3385&rft.externalDocID=S000649711850375X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon |